Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis

International Journal of Colorectal Disease · Published 2026-08-04 · DOI 10.1007/s00384-026-05210-x

Free full text

Authors (14)

Daichi Watanabe, Hironori Fujii, Yuto Miura, Misato Kani, Wakana Chikaishi, Jesse Yu Tajima, Akitaka Makiyama, Yunami Yamada, Koichi Ohata, Chiemi Hirose, Hirotoshi Iihara, Ryo Kobayashi, Nobuhisa Matsuhashi, Akio Suzuki

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Watanabe, D., Fujii, H., Miura, Y., et al. (2026). Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-026-05210-x

Related articles